Mikkel Bring Christensen

Mikkel Bring Christensen

Clinical Professor

Member of:

  • Clinical Pharmacology


  1. 2020
  2. Published

    The role of endogenous GIP and GLP-1 in postprandial bone homeostasis

    Helsted, M. M., Gasbjerg, Lærke Smidt, Lanng, A. R., Bergmann, N. C., Stensen, S., Hartmann, Bolette, Christensen, Mikkel Bring, Holst, Jens Juul, Vilsbøll, Tina, Rosenkilde, Mette & Knop, Filip Krag, 2020, In: Bone. 140, 7 p., 115553.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Two-bag intravenous N-acetylcysteine, antihistamine pretreatment and high plasma paracetamol levels are associated with a lower incidence of anaphylactoid reactions to N-acetylcysteine

    Daoud, A., Dalhoff, Kim, Christensen, Mikkel Bring, Bøgevig, S. & Petersen, Tonny Studsgaard, 2020, In: Clinical Toxicology. 58, 7, p. 698-704

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipeline

    Johansson, K. S., Sonne, D., Knop, Filip Krag & Christensen, Mikkel Bring, 2020, In: Expert Opinion on Drug Discovery. 15, 11, p. 1253-1265

    Research output: Contribution to journalReviewResearchpeer-review

  5. Published

    GIP's involvement in the pathophysiology of type 2 diabetes

    Christensen, Mikkel Bring, Gasbjerg, Lærke Smidt, Heimbürger, S. M., Stensen, S., Vilsbøll, Tina & Knop, Filip Krag, Mar 2020, In: Peptides. 125, 10 p., 170178.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Glycemic control and use of glucose-lowering medications in hospital-admitted type 2 diabetes patients over 80 years

    Gotfredsen, D. R., Vinther, S., Petersen, Tonny Studsgaard, Cortes, R., Jensen, T. B., Solem, Espen Victor Jimenez & Christensen, Mikkel Bring, Mar 2020, In: Scientific Reports. 10, 8 p., 4095.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Clinical pharmacology of imeglimin for the treatment of type 2 diabetes

    Johansson, K. S., Brønden, A., Knop, Filip Krag & Christensen, Mikkel Bring, May 2020, In: Expert Opinion on Pharmacotherapy. 21, 8, p. 871-882

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Medication-related experiences of patients with polypharmacy: a systematic review of qualitative studies

    Eriksen, C. U., Kyriakidis, S., Christensen, L. D., Jacobsen, Ramune, Laursen, J., Christensen, Mikkel Bring & Frølich, Anne, 6 Sep 2020, In: BMJ Open. 10, 9, 11 p., e036158.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Total burden of disease in cancer patients at diagnosis—a Danish nationwide study of multimorbidity and redeemed medication

    Loeppenthin, K., Dalton, Susanne Oksbjerg, Johansen, Christoffer, Andersen, E., Christensen, Mikkel Bring, Pappot, Helle, Petersen, L. N., Thisted, L. B., Frølich, A., Mortensen, C. E., Lassen, Ulrik Niels, Ørsted, J. & Bidstrup, P. E., 15 Sep 2020, In: British Journal of Cancer. 123, 6, p. 1033-1040 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 Next

ID: 96275756